167 related articles for article (PubMed ID: 22011935)
1. The adeno-associated virus-mediated HSV-TK/GCV suicide system: a potential strategy for the treatment of bladder carcinoma.
Pan JG; Zhou X; Luo R; Han RF
Med Oncol; 2012 Sep; 29(3):1938-47. PubMed ID: 22011935
[TBL] [Abstract][Full Text] [Related]
2. Suppression of bladder cancer growth in mice by adeno-associated virus vector-mediated endostatin expression.
Pan JG; Zhou X; Zeng GW; Han RF
Tumour Biol; 2011 Apr; 32(2):301-10. PubMed ID: 21052889
[TBL] [Abstract][Full Text] [Related]
3. Experimental study of the RV-HSV-TK/GCV suicide gene therapy system in gastric cancer.
Tang Q; Zhang D; Wan M; Jin L
Cancer Biother Radiopharm; 2007 Dec; 22(6):755-61. PubMed ID: 18158766
[TBL] [Abstract][Full Text] [Related]
4. Combined antitumor gene therapy with herpes simplex virus-thymidine kinase and short hairpin RNA specific for mammalian target of rapamycin.
Woo HN; Lee WI; Kim JH; Ahn J; Han JH; Lim SY; Lee WW; Lee H
Int J Oncol; 2015 Dec; 47(6):2233-9. PubMed ID: 26459571
[TBL] [Abstract][Full Text] [Related]
5. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
[TBL] [Abstract][Full Text] [Related]
6. Potent antitumour activity of the combination of HSV-TK and endostatin armed oncolytic adeno-associated virus for bladder cancer in vitro and in vivo.
Pan JG; Zhou X; Zeng GW; Han RF
J Surg Oncol; 2012 Mar; 105(3):249-57. PubMed ID: 21953122
[TBL] [Abstract][Full Text] [Related]
7. Suppression of bladder cancer growth by adeno-associated virus vector-mediated combination of HSV-TK and endostatin in vitro.
Pan JG; Luo RQ; Zhou X; Han RF; Zeng GW
Clin Lab; 2013; 59(9-10):1077-89. PubMed ID: 24273931
[TBL] [Abstract][Full Text] [Related]
8. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
9. Nanoscale bubble ultrasound contrast agents-mediated suicide gene therapy system, Nanoscale bubble-LV5-YCD-TK/GCV/5-FC, effectively inhibits bladder cancer cell growth.
Fu YR; Chen F; Luo Y; Yi YF
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):75-86. PubMed ID: 30657549
[TBL] [Abstract][Full Text] [Related]
10. Potent antitumor activity of the combination of HSV-TK and endostatin by adeno-associated virus vector for bladder cancer in vivo.
Pan JG; Luo RQ; Zhou X; Han RF; Zeng GW
Clin Lab; 2013; 59(9-10):1147-58. PubMed ID: 24273940
[TBL] [Abstract][Full Text] [Related]
11. Bifidobacterium infantis-mediated HSV-TK/GCV suicide gene therapy induces both extrinsic and intrinsic apoptosis in a rat model of bladder cancer.
Yin X; Yu B; Tang Z; He B; Ren J; Xiao X; Tang W
Cancer Gene Ther; 2013 Feb; 20(2):77-81. PubMed ID: 23258087
[TBL] [Abstract][Full Text] [Related]
12. Combined suicide gene and immunostimulatory gene therapy using AAV-mediated gene transfer to HPV-16 transformed mouse cell: decrease of oncogenicity and induction of protection.
Janousková O; Síma P; Kunke D
Int J Oncol; 2003 Mar; 22(3):569-77. PubMed ID: 12579310
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated suicide gene therapy under the control of Cox-2 promoter for colorectal cancer.
Wang ZX; Bian HB; Yang JS; De W; Ji XH
Cancer Biol Ther; 2009 Aug; 8(15):1480-8. PubMed ID: 19571664
[TBL] [Abstract][Full Text] [Related]
14. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 1. Flt3 ligand gene transfer increases antitumor effects of a radio-inducible suicide gene therapy in an ectopic tumor model.
Kawashita Y; Deb NJ; Garg M; Kabarriti R; Alfieri A; Takahashi M; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):191-200. PubMed ID: 24972258
[TBL] [Abstract][Full Text] [Related]
15. Suicide Gene Therapy for Oral Squamous Cell Carcinoma.
Faneca H; Düzgüneş N; Pedroso de Lima MC
Methods Mol Biol; 2019; 1895():43-55. PubMed ID: 30539528
[TBL] [Abstract][Full Text] [Related]
16. The cell death and DNA damages caused by the Tet-On regulating HSV-tk/GCV suicide gene system in MCF-7 cells.
Zeng ZJ; Xiang SG; Xue WW; Li HD; Ma N; Ren ZJ; Xu ZJ; Jiao CH; Wang CY; Hu WX
Biomed Pharmacother; 2014 Sep; 68(7):887-92. PubMed ID: 25217394
[TBL] [Abstract][Full Text] [Related]
17. A novel cancer vaccine strategy with combined IL-18 and HSV-TK gene therapy driven by the hTERT promoter in a murine colorectal cancer model.
Higashi K; Hazama S; Araki A; Yoshimura K; Iizuka N; Yoshino S; Noma T; Oka M
Int J Oncol; 2014 Oct; 45(4):1412-20. PubMed ID: 25051201
[TBL] [Abstract][Full Text] [Related]
18. A novel Bifidobacterium infantis-mediated TK/GCV suicide gene therapy system exhibits antitumor activity in a rat model of bladder cancer.
Tang W; He Y; Zhou S; Ma Y; Liu G
J Exp Clin Cancer Res; 2009 Dec; 28(1):155. PubMed ID: 20015348
[TBL] [Abstract][Full Text] [Related]
19. Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models.
Zheng FQ; Xu Y; Yang RJ; Wu B; Tan XH; Qin YD; Zhang QW
Acta Pharmacol Sin; 2009 May; 30(5):617-27. PubMed ID: 19363518
[TBL] [Abstract][Full Text] [Related]
20. Recombinant AAV-mediated HSVtk gene transfer with direct intratumoral injections and Tet-On regulation for implanted human breast cancer.
Li ZB; Zeng ZJ; Chen Q; Luo SQ; Hu WX
BMC Cancer; 2006 Mar; 6():66. PubMed ID: 16539746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
